Optiscan (ASX:OIL) has increased 5-fold following receipt of a milestone payment of $257,953 from leading German optical and medical devices manufacturer Carl Zeiss.
The stock opened at $0.034 on November 14th, and hit an intraday high of $0.185 today. Optiscan last traded at $0.17.
The payment was in recognition of its disposable sheath development. Carl Zeiss is also the world’s leading player in neurosurgical visualisation.
The sheath will now be integrated with Optiscan’s stand-alone rigid endomicroscopy system.
This will be deployed in the field of neurosurgery providing real time, high resolution tissue imaging at a cellular level.
Optiscan’s technologies enable high-powered microscopes to be miniaturised and used inside the body without surgically removing tissue.
This enables microscopic imaging of up to 1000 times magnification to be achieved.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.